β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.

β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.

Item
http://www.wikidata.org/entity/Q38422953
Medical management of chronic stable anginaAllopurinol and the risk of atrial fibrillation in the elderly: a study using Medicare data.Prognosis of patients with coronary artery disease treated in different therapy units at department of cardiology: a retrospective cohort studyEffectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion.Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals.Beta-Blockers and Calcium Channel Blockers: First Line Agents.Ivabradine in Patients with Stable Coronary Artery Disease: A Rationale for Use in Addition to and Beyond Percutaneous Coronary Intervention.Drug Therapy for Stable Angina Pectoris.Antianginal Therapy for Stable Ischemic Heart Disease.The Real Role of β-Blockers in Daily Cardiovascular Therapy.Does modern medicine increase life-expectancy: Quest for the Moon Rabbit?β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.β-Blocker Therapy Prior to Admission for Acute Coronary Syndrome in Patients Without Heart Failure or Left Ventricular Dysfunction Improves In-Hospital and 12-Month Outcome: Results From the GULF-RACE 2 (Gulf Registry of Acute Coronary Events-2).Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-Analysis.Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.Long-term use of carvedilol in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
P2860

β-blockers and cardiovascular events in patients with and without myocardial infarction: post hoc analysis from the CHARISMA trial.

Item
http://www.wikidata.org/entity/Q38422953
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
β-blockers and cardiovascular ...... lysis from the CHARISMA trial.
@en
type
label
β-blockers and cardiovascular ...... lysis from the CHARISMA trial.
@en
prefLabel
β-blockers and cardiovascular ...... lysis from the CHARISMA trial.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
β-blockers and cardiovascular ...... lysis from the CHARISMA trial.
@en
P2093
P304
P31
P356
10.1161/CIRCOUTCOMES.114.001073
P433
P478
P50
P577
P5875
P698